Clinical Safety and Efficacy of Pegcetacoplan in a Phase 2 Study of Patients with C3 Glomerulopathy and Other Complement-Mediated Glomerular Diseases.

Dixon, Bradley P; Greenbaum, Larry A; Huang, Liwei; Rajan, Sandeep; Ke, Chunlei; Zhang, Yiwei; Li, Li

Dixon, Bradley P; Greenbaum, Larry A; Huang, Liwei; Rajan, Sandeep; Ke, Chunlei; Zhang, Yiwei; Li, Li.

Afiliación

Dixon BP; Renal Section, Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, USA.
Greenbaum LA; Emory University and Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
Huang L; Tidewater Kidney Specialists, Inc, Chesapeake, Virginia, USA.
Rajan S; Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Ke C; Apellis Pharmaceuticals, Inc., Waltham, Massachusetts, USA.
Zhang Y; Apellis Pharmaceuticals, Inc., Waltham, Massachusetts, USA.
Li L; Apellis Pharmaceuticals, Inc., Waltham, Massachusetts, USA.

Kidney Int Rep ; 8(11): 2284-2293, 2023 Nov.

Article en En | MEDLINE | ID: mdl-38025230